Long-Term Safety and Efficacy of Moxifloxacin in Bronchiectasis Patients
NCT07274020
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
140
Enrollment
OTHER
Sponsor class
Conditions
Bronchiectasis, Non-Cystic Fibrosis
Interventions
DRUG:
Intermittent Moxifloxacin + Standard Care
OTHER:
Standard Care (in control arm)
Sponsor
Assiut University